他扎罗汀的研究进展
11］ Webster GF,Guenthor L,Poulin YP,et al.A multicenter,double?blind,randomized comparison study of the efficacy and tolerability of once?daily tazarotene 0.1% gel and adapalene 0.1% gel for the tazarotene of facial acne vulgaris［J］.Cutis,2002,69(2):4-11.
［12］ Gerald D,Weinstein MD,John YM,?et al?.Tazarotene cream in the treatment of psoriasis:two multicenter double?blind,randomized,vehicle?controlled studies of the safety and efficacy of tazarotene cream 0.05% and 0.1% applied oncedaily for 12 weeks［J］.J Am Acad Dermatol,2003,48(5):760-767.
［13］ Bershad S,Kranjac SG,Parente JE,?et al?.Successful treatment of acne vulgaris using a new method:results of a randomized vehicle?controlled trial of short?contact therapy with 0.1% tazarotene gel［J］.Arch Dermatol,2002,138(4):481-489.
［14］ Green L,Sadoff W.A Clinical evaluation of tazarotene 0.1% gel,with and without a highor mid?high?potency corticosteroid,in patients with stable plaquepsoriasis［J］.J Cutan Med Surg,2002,6(2):95-102.
［15］ Scher RK,Still M,Zhu YI.Tazarotene 0.1% gel fingernail psoriasis:a double?blind,randomized,vehicle?controlled study［J］.Cutis,2001,68(5):355-358.
［16］ Drealos ZD, Tanghetti EA.Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination?therapy［J］.Cutis,2002,69(2):20-29.
［17］ Petruzzi M,De Benedittis M,Grassi R,?
［18］ Phillips TJ,Gottlieb AB,lowe NJ,?et al?.Efficacy of 0.1% tazarotene cream for the treatment of photodamage:a 12?month multicenter,randomized trial［J］.Arch Dermatol,2002，138(11):1486-1493.
［19］ Stockfleth E,Ulrich C,Meyer T,?et al?.Epithelial malignancies in organ transplant patients:clinical presentation and new methods of treatment［J］.Recent Results Cancer Res,2002，160:251-258.
［20］ Apisarnthanarax N,Talpur R,Duvic M.Treatment of cutaneous T cell Lymphoma:current status and future directions［J］.Am J Clin Dermatol,2002,3(3):193-215.
本文链接地址：http://www.oyaya.net/fanwen/view/144612.html
［12］ Gerald D,Weinstein MD,John YM,?et al?.Tazarotene cream in the treatment of psoriasis:two multicenter double?blind,randomized,vehicle?controlled studies of the safety and efficacy of tazarotene cream 0.05% and 0.1% applied oncedaily for 12 weeks［J］.J Am Acad Dermatol,2003,48(5):760-767.
［13］ Bershad S,Kranjac SG,Parente JE,?et al?.Successful treatment of acne vulgaris using a new method:results of a randomized vehicle?controlled trial of short?contact therapy with 0.1% tazarotene gel［J］.Arch Dermatol,2002,138(4):481-489.
［14］ Green L,Sadoff W.A Clinical evaluation of tazarotene 0.1% gel,with and without a highor mid?high?potency corticosteroid,in patients with stable plaquepsoriasis［J］.J Cutan Med Surg,2002,6(2):95-102.
［15］ Scher RK,Still M,Zhu YI.Tazarotene 0.1% gel fingernail psoriasis:a double?blind,randomized,vehicle?controlled study［J］.Cutis,2001,68(5):355-358.
［16］ Drealos ZD, Tanghetti EA.Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination?therapy［J］.Cutis,2002,69(2):20-29.
［17］ Petruzzi M,De Benedittis M,Grassi R,?
et al?.Oral lichen planus:a preliminary clinical study on treatment with tazarotene［J］.Oral Dis,2002,8(6):291-295.
［18］ Phillips TJ,Gottlieb AB,lowe NJ,?et al?.Efficacy of 0.1% tazarotene cream for the treatment of photodamage:a 12?month multicenter,randomized trial［J］.Arch Dermatol,2002，138(11):1486-1493.
［19］ Stockfleth E,Ulrich C,Meyer T,?et al?.Epithelial malignancies in organ transplant patients:clinical presentation and new methods of treatment［J］.Recent Results Cancer Res,2002，160:251-258.
［20］ Apisarnthanarax N,Talpur R,Duvic M.Treatment of cutaneous T cell Lymphoma:current status and future directions［J］.Am J Clin Dermatol,2002,3(3):193-215.
《他扎罗汀的研究进展(第3页)》
★读了本文的人也读了：